Advertisement

Prenatal Syphilis Screening Among Medicaid Enrollees in 6 Southern States

Published:January 05, 2022DOI:https://doi.org/10.1016/j.amepre.2021.11.011

      Introduction

      The rates of syphilis among pregnant women and infants have increased in recent years, particularly in the U.S. South. Although state policies require prenatal syphilis testing, recent screening rates comparable across Southern states are not known. The purpose of this study is to measure syphilis screening among Medicaid enrollees with delivery in states in the U.S. South.

      Methods

      A total of 6 state–university research partnerships in the U.S. South developed a distributed research network to analyze Medicaid claims data using a common analytic approach for enrollees with delivery in fiscal years 2017–2018 and 2018–2019 (combined N=504,943). In 2020–2021, each state calculated the percentage of enrollees with delivery with a syphilis screen test during the first trimester, third trimester, and at any point during pregnancy. Percentages for those with first-trimester enrollment were compared with the percentages of those who enrolled in Medicaid later in pregnancy.

      Results

      Prenatal syphilis screening during pregnancy ranged from 56% to 91%. Screening was higher among those enrolled in Medicaid during the first trimester than in those enrolled later in pregnancy.

      Conclusions

      Despite state laws requiring syphilis screening during pregnancy, screening was much lower than 100%, and states varied in syphilis screening rates among Medicaid enrollees. Findings indicate that access to Medicaid in the first trimester is associated with higher rates of syphilis screening and that efforts to improve access to screening in practice settings are needed.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Preventive Services Task Force U.S.
        • Curry SJ
        • Krist AH
        • et al.
        Screening for syphilis infection in pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement.
        JAMA. 2018; 320: 911-917https://doi.org/10.1001/jama.2018.11785
      1. Sexually transmitted disease surveillance 2019. Centers for Disease Control and Prevention. https://www.cdc.gov/std/statistics/2019/default.htm. Updated July 29, 2021. Accessed November 16, 2021.

        • Workowski KA
        • Bolan GA
        Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015.
        MMWR Recomm Rep. 2015; 64 ([published correction appears in MMWR Recomm Rep. 2015;64(33):924]) (Accessed November 16, 2021): 1-137https://doi.org/10.15585/mmwr.rr7004a1
        • Southwick KL
        • Guidry HM
        • Weldon MM
        • Mert KJ
        • Berman SM
        • Levine WC.
        An epidemic of congenital syphilis in Jefferson County, Texas, 1994-1995: inadequate prenatal syphilis screening after an outbreak in adults.
        Am J Public Health. 1999; 89: 557-560https://doi.org/10.2105/ajph.89.4.557
        • Desenclos JC
        • Scaggs M
        • Wroten JE.
        Characteristics of mothers of live infants with congenital syphilis in Florida, 1987-1989.
        Am J Epidemiol. 1992; 136: 657-661https://doi.org/10.1093/oxfordjournals.aje.a116545
        • Mobley JA
        • McKeown RE
        • Jackson KL
        • Sy F
        • Parham JS
        • Brenner ER.
        Risk factors for congenital syphilis in infants of women with syphilis in South Carolina.
        Am J Public Health. 1998; 88: 597-602https://doi.org/10.2105/ajph.88.4.597
        • Tsai S
        • Sun MY
        • Kuller JA
        • Rhee EHJ
        Dotters-Katz S. Syphilis in pregnancy.
        Obstet Gynecol Surv. 2019; 74: 557-564https://doi.org/10.1097/OGX.0000000000000713
        • Kaiser Family Foundation
        Medicaid's role for women.
        Kaiser Family Foundation, San Francisco, CA2019 (Published March 28Accessed November 16, 2021)
        • Medicaid and CHIP Payment and Access Commission
        June 2020 Report to Congress on Medicaid and CHIP.
        Medicaid and CHIP Payment and Access Commission, Washington, DC2020 (Published JuneAccessed November 16, 2021)
        • Pearson WS
        • Spicknall IH
        • Cramer R
        • Jenkins WD.
        Medicaid coverage of sexually transmitted disease service visits.
        Am J Prev Med. 2019; 57: 51-56https://doi.org/10.1016/j.amepre.2019.02.019
        • Harling G
        • Subramanian S
        • Bärnighausen T
        • Kawachi I.
        Socioeconomic disparities in sexually transmitted infections among young adults in the United States: examining the interaction between income and race/ethnicity.
        Sex Transm Dis. 2013; 40: 575-581https://doi.org/10.1097/OLQ.0b013e31829529cf
        • Rosenman MB
        • Tao G
        • Szucs KA
        • Wang J
        • Ambuehl R
        • Mahon BE.
        Prenatal syphilis screening rates measured using Medicaid claims and electronic medical records.
        Sex Transm Dis. 2008; 35: 387-392https://doi.org/10.1097/OLQ.0b013e31815fa5bb
        • Wilson EK
        • Gavin NI
        • Adams EK
        • Tao G
        Chireau M. Patterns in prenatal syphilis screening among Florida Medicaid enrollees.
        Sex Transm Dis. 2007; 34: 378-383https://doi.org/10.1097/01.olq.0000245908.23629.b8
        • Fowler CI
        • Gavin NI
        • Adams EK
        • Tao G
        • Chireau M
        Racial and ethnic disparities in prenatal syphilis screening among women with Medicaid-covered deliveries in Florida.
        Matern Child Health J. 2008; 12: 378-393https://doi.org/10.1007/s10995-007-0247-7
        • Adams EK
        • Gavin NI
        • Raskind-Hood C
        • Tao G.
        Explaining racial differences in prenatal care initiation and syphilis screening among Medicaid-covered pregnant women.
        J Health Care Poor Underserved. 2009; 20: 177-193https://doi.org/10.1353/hpu.0.0099
        • Ross CE
        • Tao G
        • Patton M
        • Hoover KW.
        Screening for human immunodeficiency virus and other sexually transmitted diseases among U.S. women with prenatal care.
        Obstet Gynecol. 2015; 125: 1211-1216https://doi.org/10.1097/AOG.0000000000000756
        • Aslam MV
        • Owusu-Edusei K
        • Kidd SE
        • Torrone EA
        • Dietz PM.
        Increasing syphilis diagnoses among females giving birth in U.S. hospitals, 2010-2014.
        Sex Transm Dis. 2019; 46: 147-152https://doi.org/10.1097/OLQ.0000000000000945
        • Gregory ECW
        • Ely DM.
        Trends and characteristics of sexually transmitted infections during pregnancy: United States, 2016‒2018.
        Natl Vital Stat Rep. 2020; 69 (https://pubmed.ncbi.nlm.nih.gov/32510315/. Accessed November 16, 2021): 1-11
        • Kroeger KA
        • Sangaramoorthy T
        • Loosier PS
        • Schmidt R
        • Gruber D.
        Pathways to congenital syphilis prevention: a rapid qualitative assessment of barriers, and the public health response, in Caddo Parish.
        Louisiana. Sex Transm Dis. 2018; 45: 442-446https://doi.org/10.1097/OLQ.0000000000000787
        • Adams L
        • Kennedy S
        • Allen L
        • et al.
        Innovative solutions for state Medicaid programs to leverage their data, build their analytic capacity, and create evidence-based policy.
        EGEMS (Wash DC). 2019; 7: 41https://doi.org/10.5334/egems.311
      2. Natality information—live births. Centers for Disease Control and Prevention. https://wonder.cdc.gov/natality.html. Accessed November 24, 2021.

        • Motulsky HJ.
        Common misconceptions about data analysis and statistics.
        Pharmacol Res Perspect. 2015; 3: e00093https://doi.org/10.1002/prp2.93
        • Hayes-Larson E
        • Kezios KL
        • Mooney SJ
        • Lovasi G.
        Who is in this study, anyway? Guidelines for a useful table 1.
        J Clin Epidemiol. 2019; 114: 125-132https://doi.org/10.1016/j.jclinepi.2019.06.011